20. November 2009 08:37
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
[More]
f23b18ab-0bd0-4d21-ad99-95fb9aaafa02|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Anemia, Arthritis, Asthma, Biotechnology, Bone, Bone Mineral Density, Cancer, Cell, Gene Expression, Gerontology, Osteoporosis, Pfizer, Psoriasis, Rheumatoid Arthritis, Sexual Dysfunction, Testosterone
20. November 2009 00:42
A workshop on "Neuroeconomics and Endocrinological Economics," to be held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers.
[More]
19. November 2009 05:44
Researchers from the German Sport University Cologne in Germany found that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are being sold on the black market for their performance enhancing qualities.
[More]
17. November 2009 03:13
BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need.
[More]
ce48eec0-1716-4988-864d-6c11cc5f5d0b|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Brain, Calcium, Cancer, Cell, Contraception, Dopamine, Drug Delivery, Erectile Dysfunction, Estradiol, Estrogen, H1N1, Menopause, New Drug Application, Serotonin, Sexual Dysfunction, Sleep, Swine Flu, Testosterone, Vaccine
16. November 2009 06:11
A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, such as trucks and play fighting.
[More]
16. November 2009 02:53
Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.
[More]
26763d0f-0495-4959-b205-21577d755a4e|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Blood Pressure, Bone, Cancer, Cardiology, Cardiovascular Disease, Cholesterol, Estrogen, Hospital, Nutrition, Osteopenia, Osteoporosis, Steroid, Stroke, Testosterone, Vitamin D, Vitamin D Deficiency
13. November 2009 01:51
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.
[More]
c564e810-ed6e-4f81-81a1-0b47d359140f|0|.0
Posted in: Men's Health News | Medical Research News
Tags: Anemia, Cancer, Cardiovascular Disease, Dermatology, Diabetes, Gerontology, Immunization, Kidney Disease, Nutrition, Stroke, Testosterone, Vaccine
13. November 2009 01:39
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
[More]
9. November 2009 08:50
In their American Society of Reproductive Medicine (ASRM) conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections (IM progesterone) for luteal support in infertility treatment.
[More]
eae6ffa9-f485-4ce6-8179-2b0c8cd4ba70|0|.0
Posted in: Women's Health News | Pharmaceutical News
Tags: Abortion, Constipation, Endocrinology, Exercise, Fertility, Headache, Hospital, Infertility, IVF, Menstruation, Nausea, Obstetrics, Ovulation, Pregnancy, Progesterone, Testosterone, Ultrasound
6. November 2009 03:16
CPEX Pharmaceuticals, Inc. today announced that its intranasal insulin product candidate, NasulinTM, will be featured in an oral presentation and four abstracts at the Ninth Annual Diabetes Technology Meeting, November 5-7, 2009 at the Hyatt Regency Airport in San Francisco, California.
[More]
5. November 2009 07:35
Columbia Laboratories, Inc. today reported financial results for the three- and nine-month periods ended September 30, 2009.
[More]
4. November 2009 07:37
CPEX Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2009. For the quarter CPEX reported revenues of $5.0 million and a net loss of $872,000.
[More]
4. November 2009 04:10
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
[More]
2. November 2009 23:58
Penn Medicine will lead a new national $45 million clinical trial to test whether testosterone therapy can favorably affect certain conditions affecting older men. Low serum testosterone may contribute to a number of problems affecting older men, including decreased ability to walk, loss of muscle mass and strength, decreased vitality, decreased sexual function, impaired cognition, cardiovascular disease and anemia. While testosterone normally decreases with age, in some men, low levels of testosterone may contribute to these debilitating conditions.
[More]
267244c6-5b02-4703-9c33-7c8cf08191fa|0|.0
Posted in: Men's Health News | Medical Research News
Tags: Anemia, Cardiovascular Disease, Diabetes, Education, Endocrinology, Gerontology, Hospital, Metabolism, Nursing, Stroke, Testosterone
30. October 2009 08:16
Repros Therapeutics today announced that the Company has entered into a settlement agreement with its major creditors for the large majority of the debt incurred associated with the recently suspended Proellex® clinical program.
[More] 
Subscribe